David A. Savitz – författare

Epidemiology, the so-called "science of public health," has undergone a boom in the last decade as public interest and engagement in population health has skyrocketed. While this boom has done much to spark advances in the technology of epidemiology, it has also made it harder for those who want to use epidemiology to guide policy and clinical practice to fully appreciate the meaning of the research findings. Interpreting Epidemiologic Evidence offers those who have had an introductory course in epidemiology the knowledge they need to make clear connections from research findings to practical applications. Written in clear and lively prose, it empowers students at all levels to evaluate a study's design, implementation, and ultimate findings, giving the guidance needed to apply the information appropriately. Liberal use of practical examples serves both to illustrate core concepts and to motivate readers to think critically about the causal connections that population health studies aim to explore.Completely revised and updated, this new edition of Interpreting Epidemiologic Evidence is an invaluable core text for both epidemiologists in training and practitioners across other disciplines with even an introductory knowledge of epidemiology.

This book gives a comprehensive survey of the epidemiology of common environmental exposures, including diet, water, particulates in outdoor air, nitrogen dioxide, ozone, environmental tobacco smoke, radon in homes, electromagnetic fields, and lead. Design and analysis issues, risk assessment and meta-analysis, and future directions in environmental epidemiology are also covered. All chapters provide a review of the literature as well as a discussion of important methodologic issues, particularly exposure assessment and statistical methods. The book's focus is on environmental exposures that are suspected of causing disease, but often remain controversial. Most of these exposures are widespread and low-level, and are thought to increase the risk of chronic diseases that have many causes. Although the disease risks due to these exposures may be low, the public health burden may be important because large numbers of people are exposed. Such exposures are inherently difficult to detect via observational epidemiology. This book seeks to clarify the challenges involved and suggests ways to move forward. It will be useful to students and practitioners of public health, environmental health, and epidemiology.

Among the many who serve in the United States Armed Forces and who are deployed to distant locations around the world, myriad health threats are encountered. In addition to those associated with the disruption of their home life and potential for combat, they may face distinctive disease threats that are specific to the locations to which they are deployed. U.S. forces have been deployed many times over the years to areas in which malaria is endemic, including in parts of Afghanistan and Iraq. Department of Defense (DoD) policy requires that antimalarial drugs be issued and regimens adhered to for deployments to malaria-endemic areas. Policies directing which should be used as first and as second-line agents have evolved over time based on new data regarding adverse events or precautions for specific underlying health conditions, areas of deployment, and other operational factorsAt the request of the Veterans Administration, Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis assesses the scientific evidence regarding the potential for long-term health effects resulting from the use of antimalarial drugs that were approved by FDA or used by U.S. service members for malaria prophylaxis, with a focus on mefloquine, tafenoquine, and other antimalarial drugs that have been used by DoD in the past 25 years. This report offers conclusions based on available evidence regarding associations of persistent or latent adverse events.